Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated 2024 guidance reflects performance improvement but includes costs tied to ...
“We should all care about health equity because that is one more person who is going to have a challenge to care for their ...
The innovative medicine and medtech segments showed solid sales growth. Johnson & Johnson reported a strong increase in sales, but earnings fell due to one-time charges. In the wake of last year's ...
Michigan football defensive back Will Johnson didn't need to say anything specific, his body language did the talking on ...
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
Johnson, 52, posted three clips showing how his “Face The Nation” answers on topics including hurricane relief and election ...
"Dancing with the Stars" partners Joey Graziadei and Jenna Johnson sounded off on the impressive amount of water Joey drinks ...
Terms for the boards begin Jan. 1, 2025. To apply for one of the open board seats, fill out the Board Appointment Interest ...
It was a relatively quiet day for Pittsburgh Pirates No. 3 prospect Termarr Johnson in his return to the lineup in the ...
Bears cornerback Jaylon Johnson has excelled in pass-coverage this year, leading the league in passer-rating allowed.
David Risinger, an analyst from Leerink Partners, maintained the Buy rating on Johnson & Johnson (JNJ – Research Report). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback